YANG, L,
LI, Y,
GONG, R,
GAO, M.Q.,
FENG, C,
LIU, T.Y.,
SUN, Y,
JIN, M.Y.,
WANG, D.W.,
YUAN, Y,
YAN, G.G.,
HE, M.Y.,
IDIYATULLINA, E.T.,
MA, W.Y.,
HAN, Z.B.,
ZHANG, L,
HUANG, Q.,
DING, F.Z.,
CAI, B.Z.,
CAI, B.Z.,
YANG, F. (2019) frequency of BPPV in MD was 14% (95% CI
9–18%). It was 38% (95% CI 26–49%) in longitudinal studies and 8
KAZANTSEVA, A.V.,
DAVYDOVA, YU.D.,
ENIKEEVA, R.F.,
LOBASKOVA, M.M.,
MUSTAFIN, R.N.,
MALYKH, S.B.,
TAKHIROVA, Z.R.,
KHUSNUTDINOVA, E.K. (2020) models (PLINK v.1.
9) adjusted for multiple comparisons. Results: We observed ethnicity-specific main
SEREDA, Y.,
KIRIAZOVA, T.,
MAKARENKO, O.,
CARROLL, J.J.,
RYBAK, N.,
GILLANI, F.S.,
FLANIGAN, T.,
CHYBISOV, A.,
BENDIKS, S.,
DUTTA, A.,
SAMET, J.H.,
LUNZE, K.,
IDRISOV, B. (2020) was associated with suicide attempts (adjusted beta (aβ): 5.90; 95% CI: 2.05,
9.75), and substance use stigma
KURKINA, M.V.,
MIHAYLOVA, S.V.,
BAIDAKOVA, G.V.,
SAIFULLINA, E.V.,
KOROSTELEV, S.A.,
PYANKOV, D.V.,
KANIVETS, I.V.,
YUNIN, M.A.,
PECHATNIKOVA, N.L.,
ZAKHAROVA, E.YU (2020) identified a total of 21 variants,
9 of which were novel: c.127 + 1G > T, с.471_473delCGA, c.161 T > C (p
ATAS, A.E.,
SARAC, A.,
DIRICAN, A.,
TOPBASI, N.,
UZAR, T.,
RASTGAR, L.,
PANKINA, E.,
OZKAYA, S. (2019)
of thrombolytic treatment. The overall mortality rate was 26.2% (n = 19), and 12.5% (n =
9) of the
patients have
ARUTYUNYAN, V.,
SINELNIKOV, Y.,
KADYRALIEV, B.,
BARANOV, A.,
CHERNOV, I.,
ENGINOEV, S.,
KOMAROV, R.,
TCHEGLOV, M.,
ISMAILBAEV, A.,
ASHUROV, F.,
CLAVEL, M.A.,
PIBAROT, P.,
SÁ M.P.B.O.,
WEYMANN, A.,
ZHIGALOV, K. (2020) and over 95% were operated for aortic stenosis. Preoperatively, pressure gradients were 69.
9±21.3 mm
associated with essential
hypertension (OR=0.51, PFDR=
9.56x10–4 for the C allele). Using multilocus approach